Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mikhail Kogan

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Journal of Alternative and Complementary Medicine (New York, N.Y.)|June 26, 2019
A Feasibility Study of Group-Delivered Behavioral Interventions for Insomnia Among Breast Cancer Survivors: Comparing Cognitive Behavioral Therapy for Insomnia and a Mind-Body InterventionHannah Arem, Daniel Lewin, Gabriella Cifu, et al.
Global Advances in Integrative Medicine and Health|June 1, 2026
The Integrative Personalized Functional Medicine Approach to Reverse Cognitive Decline: Academic Experience of the First 51 Patients Case SeriesMikhail Kogan, Leigh A Frame, Mehrshad Fahim Devin, et al.
BMC Neurology|March 16, 2022
Boston cognitive assessment (BOCA) - a comprehensive self-administered smartphone- and computer-based at-home test for longitudinal tracking of cognitive performanceAndrey Vyshedskiy, Rebecca Netson, Elisabeth Fridberg, et al.
The American Journal of Medicine|July 18, 2025
Reimagining Integrative Medicine Fellowship Core Competencies with a Health Equity LensVincent Minichiello, Melinda Ring, Shelley R Adler, et al.
The Lancet. Oncology|October 11, 2016
IMA901, a multipeptide cancer vaccine, plus sunitinib versus sunitinib alone, as first-line therapy for advanced or metastatic renal cell carcinoma (IMPRINT): a multicentre, open-label, randomised, controlled, phase 3 trialBrian I Rini, Arnulf Stenzl, Romauld Zdrojowy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2013
Tivozanib versus sorafenib as initial targeted therapy for patients with metastatic renal cell carcinoma: results from a phase III trialRobert J Motzer, Dmitry Nosov, Timothy Eisen, et al.
Gut Microbes Reports|June 12, 2026
Brain health and the gut microbiome (bMicrobiome Study): a proof-of-concept, feasibility study integrating shotgun metagenomics, metrology, and multidimensional phenotyping across the cognitive aging spectrumLeigh A Frame, Alison Warren, Abdelmohsen Al Qalam, et al.
JAMA Network Open|October 7, 2025
Developing Medical Cannabis Competencies: A Consensus StatementYuval Zolotov, Leslie Mendoza Temple, Richard Isralowitz, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Alternative and Complementary Medicine (New York, N.Y.)|June 26, 2019
A Feasibility Study of Group-Delivered Behavioral Interventions for Insomnia Among Breast Cancer Survivors: Comparing Cognitive Behavioral Therapy for Insomnia and a Mind-Body InterventionHannah Arem, Daniel Lewin, Gabriella Cifu, et al.
Global Advances in Integrative Medicine and Health|June 1, 2026
The Integrative Personalized Functional Medicine Approach to Reverse Cognitive Decline: Academic Experience of the First 51 Patients Case SeriesMikhail Kogan, Leigh A Frame, Mehrshad Fahim Devin, et al.
BMC Neurology|March 16, 2022
Boston cognitive assessment (BOCA) - a comprehensive self-administered smartphone- and computer-based at-home test for longitudinal tracking of cognitive performanceAndrey Vyshedskiy, Rebecca Netson, Elisabeth Fridberg, et al.
The American Journal of Medicine|July 18, 2025
Reimagining Integrative Medicine Fellowship Core Competencies with a Health Equity LensVincent Minichiello, Melinda Ring, Shelley R Adler, et al.
The Lancet. Oncology|October 11, 2016
IMA901, a multipeptide cancer vaccine, plus sunitinib versus sunitinib alone, as first-line therapy for advanced or metastatic renal cell carcinoma (IMPRINT): a multicentre, open-label, randomised, controlled, phase 3 trialBrian I Rini, Arnulf Stenzl, Romauld Zdrojowy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2013
Tivozanib versus sorafenib as initial targeted therapy for patients with metastatic renal cell carcinoma: results from a phase III trialRobert J Motzer, Dmitry Nosov, Timothy Eisen, et al.
Gut Microbes Reports|June 12, 2026
Brain health and the gut microbiome (bMicrobiome Study): a proof-of-concept, feasibility study integrating shotgun metagenomics, metrology, and multidimensional phenotyping across the cognitive aging spectrumLeigh A Frame, Alison Warren, Abdelmohsen Al Qalam, et al.
JAMA Network Open|October 7, 2025
Developing Medical Cannabis Competencies: A Consensus StatementYuval Zolotov, Leslie Mendoza Temple, Richard Isralowitz, et al.
Pageof 3